• Perguntas frequentes
  • Glossário
Fechar

Perguntas frequentes

Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

Ver todas as FAQs

Fechar

Glossário

Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial

Ver o glossário completo

Case Studies

This section contains case studies on ATMP development. Follow the links below to learn about the development processes, the keys to success, the challenges and how developers overcame them: 

Case study: Holoclar

learn about the development of Holoclar, a Tissue Engineered Product (TEP)
Go to case study

Case Study: Strimvelis

learn about the development of Strimvelis, a Gene Therapy Medicinal Product (GTMP)
Go to case study

Case Study: Therapy Classification

Early therapy classification considerations in developing skin equivalents
Go to case study

  

Back to Research Pathways

Voltar ao topo
Achou o conteúdo desta página útil? Se não, pode deixar-nos uma mensagem para que possamos melhorar Envie-nos as suas ideias